A
Albireo Pharma Inc
F:BDQM
Albireo Pharma Inc
F:BDQM
Price:
41.41
EUR
0.46%
Market Closed
Market Cap:
€857.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Albireo Pharma Inc
F:BDQM
|
US |
|
Cooper-Standard Holdings Inc
NYSE:CPS
|
US |
|
National Australia Bank Ltd
ASX:NAB
|
AU |
|
V
|
Very Good Food Company Inc
XTSX:VERY
|
CA |
|
Coca-Cola Co
NYSE:KO
|
US |
|
X
|
Xero Ltd
F:0XE
|
NZ |
|
Wilmar International Ltd
SGX:F34
|
SG |
|
Insulet Corp
NASDAQ:PODD
|
US |
|
Amplitude Inc
NASDAQ:AMPL
|
US |
|
C
|
China Literature Ltd
OTC:CHLLF
|
CN |
|
American Airlines Group Inc
NASDAQ:AAL
|
US |
|
Procter & Gamble Co
NYSE:PG
|
US |
|
D
|
Dr Reddy's Laboratories Ltd
F:RDDA
|
IN |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BDQM's stock price target?
Not Available
BDQM does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Albireo Pharma Inc?
Projected CAGR
36%
36%
The compound annual growth rate for Revenue over the next 1 year is 36%.
